Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy Burgess

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Current Medical Research and Opinion|December 7, 2010
Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-mediated vasodilatationJohn J P Kastelein, Raphaël Duivenvoorden, John Deanfield, et al.
Lancet (London, England)|September 13, 2011
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trialZahi A Fayad, Venkatesh Mani, Mark Woodward, et al.
Respiratory Research|May 21, 2022
Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension studyGanesh Raghu, Mark J Hamblin, A Whitney Brown, et al.
Nature Medicine|November 9, 2021
Fenebrutinib in H<sub>1</sub> antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trialMartin Metz, Gordon Sussman, Rémi Gagnon, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2016
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant RecipientsJulie H Ishida, Anita Patel, Aneesh K Mehta, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2017
Reply to Hunsberger and Memoli, "Efficacy Analysis in Healthy-Volunteer Influenza Challenge Trials: Intention To Treat"Jacqueline M McBride, Jeremy J Lim, Tracy Burgess, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2017
Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge ModelJacqueline M McBride, Jeremy J Lim, Tracy Burgess, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Current Medical Research and Opinion|December 7, 2010
Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-mediated vasodilatationJohn J P Kastelein, Raphaël Duivenvoorden, John Deanfield, et al.
Lancet (London, England)|September 13, 2011
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trialZahi A Fayad, Venkatesh Mani, Mark Woodward, et al.
Respiratory Research|May 21, 2022
Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension studyGanesh Raghu, Mark J Hamblin, A Whitney Brown, et al.
Nature Medicine|November 9, 2021
Fenebrutinib in H<sub>1</sub> antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trialMartin Metz, Gordon Sussman, Rémi Gagnon, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2016
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant RecipientsJulie H Ishida, Anita Patel, Aneesh K Mehta, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2017
Reply to Hunsberger and Memoli, "Efficacy Analysis in Healthy-Volunteer Influenza Challenge Trials: Intention To Treat"Jacqueline M McBride, Jeremy J Lim, Tracy Burgess, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2017
Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge ModelJacqueline M McBride, Jeremy J Lim, Tracy Burgess, et al.
Pageof 2